Penserra Capital Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $48K | Sell |
198
-6
| -3% | -$1.4K | ﹤0.01% | 775 |
|
|
2025
Q4 | $42K | Buy |
204
+12
| +6% | +$2.37K | ﹤0.01% | 779 |
|
|
2025
Q3 | $35K | Buy |
192
+51
| +36% | +$8.74K | ﹤0.01% | 812 |
|
|
2025
Q2 | $21K | Sell |
141
-5,899
| -98% | -$907K | ﹤0.01% | 797 |
|
|
2025
Q1 | $1M | Sell |
6,040
-199
| -3% | -$31.1K | 0.02% | 434 |
|
|
2024
Q4 | $901K | Buy |
6,239
+6,098
| +4,325% | +$945K | 0.02% | 426 |
|
|
2024
Q3 | $22K | Sell |
141
-39
| -22% | -$6.21K | ﹤0.01% | 865 |
|
|
2024
Q2 | $26K | Buy |
180
+3
| +2% | +$446 | ﹤0.01% | 904 |
|
|
2024
Q1 | $27K | Sell |
177
-582,187
| -100% | -$92.7M | ﹤0.01% | 899 |
|
|
2023
Q4 | $91.3M | Buy |
582,364
+41,553
| +8% | +$6.37M | 1.72% | 18 |
|
|
2023
Q3 | $84.2M | Sell |
540,811
-374,614
| -41% | -$61.8M | 1.74% | 18 |
|
|
2023
Q2 | $152M | Buy |
915,425
+35,106
| +4% | +$5.67M | 3% | 7 |
|
|
2023
Q1 | $136M | Buy |
880,319
+132,238
| +18% | +$21.4M | 2.83% | 8 |
|
|
2022
Q4 | $132M | Buy |
748,081
+183,979
| +33% | +$31.8M | 2.9% | 7 |
|
|
2022
Q3 | $92.2M | Buy |
564,102
+112,101
| +25% | +$19M | 2.61% | 3 |
|
|
2022
Q2 | $80.2M | Buy |
452,001
+236,289
| +110% | +$42.1M | 2.18% | 2 |
|
|
2022
Q1 | $38.2M | Buy |
215,712
+56,376
| +35% | +$9.59M | 0.91% | 26 |
|
|
2021
Q4 | $27.3M | Sell |
159,336
-48,738
| -23% | -$7.98M | 0.58% | 41 |
|
|
2021
Q3 | $33.6M | Buy |
208,074
+47,432
| +30% | +$8.09M | 0.7% | 25 |
|
|
2021
Q2 | $26.5M | Buy |
160,642
+53,900
| +50% | +$8.92M | 0.48% | 53 |
|
|
2021
Q1 | $17.5M | Buy |
106,742
+68,716
| +181% | +$11.1M | 0.32% | 79 |
|
|
2020
Q4 | $5.98M | Buy |
38,026
+17,596
| +86% | +$2.6M | 0.14% | 155 |
|
|
2020
Q3 | $3.04M | Buy |
20,430
+12,695
| +164% | +$1.88M | 0.12% | 173 |
|
|
2020
Q2 | $1.09M | Sell |
7,735
-1,385
| -15% | -$202K | 0.06% | 248 |
|
|
2020
Q1 | $1.2M | Buy |
9,120
+2,120
| +30% | +$301K | 0.08% | 228 |
|
|
2019
Q4 | $1.05M | Sell |
7,000
-7,135
| -50% | -$968K | 0.07% | 290 |
|
|
2019
Q3 | $1.83M | Buy |
14,135
+1,088
| +8% | +$143K | 0.16% | 122 |
|
|
2019
Q2 | $1.81M | Buy |
13,047
+946
| +8% | +$131K | 0.14% | 126 |
|
|
2019
Q1 | $1.71M | Sell |
12,101
-3,760
| -24% | -$504K | 0.14% | 110 |
|
|
2018
Q4 | $2.05M | Buy |
15,861
+2,033
| +15% | +$284K | 0.2% | 95 |
|
|
2018
Q3 | $1.91M | Buy |
+13,828
| New | +$1.84M | 0.12% | 121 |
|
|
2018
Q2 | – | Sell |
-5,333
| Closed | -$683K | – | 576 |
|
|
2018
Q1 | $683K | Buy |
5,333
+980
| +23% | +$132K | 0.06% | 146 |
|
|
2017
Q4 | $608K | Buy |
4,353
+1,153
| +36% | +$161K | 0.08% | 120 |
|
|
2017
Q3 | $416K | Buy |
+3,200
| New | +$424K | 0.1% | 106 |
|
Other funds holding JNJ
VCM
VPM
Penserra Capital Management's JNJ Position: Q1 2026 in Review
Penserra Capital Management reduced its Johnson & Johnson (JNJ) stake by 2.9% in Q1 2026, selling an estimated $1.4K and leaving 198 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #775.
Penserra Capital Management first reported a position in JNJ in Q3 2017 and has held it in 34 quarters since. The position peaked at $152M in Q2 2023. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Penserra Capital Management held 198 shares of Johnson & Johnson worth $48K as of Q1 2026.
- Penserra Capital Management sold 6 Johnson & Johnson shares in Q1 2026, an estimated $1.4K.
- Johnson & Johnson made up ﹤0.01% of Penserra Capital Management's portfolio in Q1 2026, its #775 holding.
- Penserra Capital Management first reported a position in Johnson & Johnson in Q3 2017 and has held it in 34 quarters since.
- Penserra Capital Management's Johnson & Johnson position peaked at $152M in Q2 2023.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Penserra Capital Management's 13F filing for Q1 2026, filed 11 May 2026.